HIGHLIGHTS
- who: Jeyanthi Ramanarayanan and Ganapathy Krishnan from the Nancy Nand JC. Lewis and Research Pavilion at St. Joseph's Candler Hospital, Jesup, USA have published the research: Immunotherapy in Early Stage Non-Small Cell Lung Cancer, in the Journal: (JOURNAL)
- what: Cancer immunotherapy has induced long-term responses and improved survival in a proportion of patients with locally advanced and metastatic lung cancer.
- how: The results showed that patients treated with SBRT combined with pembrolizumab had improved median PFS (6.6 months vs. 1.9 months p=0.19) and overall survival rates . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.